Gastric-type Endocervical Adenocarcinoma

• CLINICAL_TRIALS research · 2026-01-13
  Clinical Trial Update: IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial [Phase 2]

  Phase 2 trial update noting that IN10018 combined with nab-paclitaxel and cadonilimab for metastatic or recurrent gastric-type cervical aden…

• CLINICAL_TRIALS trial_result · 2025-06-18
  Clinical Trial Update: Surgical Resection Enhances Survival in Gastric-type Endocervical Adenocarcinoma: A SEER-Based Study

  A completed SEER-based study suggests that surgical resection may improve survival in patients with gastric-type endocervical adenocarcinoma…

• CLINICAL_TRIALS research · 2025-03-26
  Clinical Trial Update: Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study

  Completed population-based cohort study evaluating gastric-type endocervical adenocarcinoma, a histologic subtype of cervical cancer. The st…

• CLINICAL_TRIALS research · 2025-03-17
  Clinical Trial Update: Comparative Study of Adjuvant Therapy for Postoperative Cervical Gastric-type Adenocarcinoma [Phase 3]

  A Phase 3 clinical trial is evaluating adjuvant therapy after surgery for gastric-type endocervical adenocarcinoma. The study status is NOT_…

• CLINICAL_TRIALS research · 2024-12-10
  Clinical Trial Update: A Study of WX390 Combined With Toripalimab in Patients With Advanced Gastric-type Endocervical Adenocarcinoma With STK11 Mutations [Phase 2]

  Phase 2 trial investigating WX390 in combination with toripalimab for advanced gastric-type endocervical adenocarcinoma with STK11 mutations…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.